About DCAT Week 2025
ICE Pharma attended DCAT Week 2025 which took place in New York City from 17th – 20th March, 2025.
We had an incredible experience at DCAT in New York City! We sincerely thank everyone who visited us and took the time to connect.
It was truly inspiring to engage with so many industry leaders, innovators, and partners, both current and potential. We’re excited about the opportunities and collaborations that lie ahead.
Stay tuned for updates as we continue to innovate and shape the future of the industry.
Who We Are
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets
Founded more than 70 years ago, the Company has a network of manufacturing facilities and subsidiaries in North and South America, Europe, Asia and Oceania. We commercialise our products and services in all the major global markets and serve customers in over 50 countries.
We are a key supplier to the pharmaceutical industry providing a range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. We also supply excipients, cell culture media for diagnostics, GMP intermediates and research chemicals. Our services business provides contract manufacturing for solid and liquid finished dosage forms.
We manufacture and commercialise branded products in the pharmaceutical, nutraceutical and cosmetics markets.